These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28688130)

  • 1. The pharmaceutical industry needs more clinical pharmacologists.
    Peck R
    Br J Clin Pharmacol; 2017 Nov; 83(11):2343-2346. PubMed ID: 28688130
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug development and the FDA's Critical Path Initiative.
    Woosley RL; Cossman J
    Clin Pharmacol Ther; 2007 Jan; 81(1):129-33. PubMed ID: 17186012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The UK's Life Sciences Strategy: opportunities for clinical pharmacology.
    Rawlins MD
    Br J Clin Pharmacol; 2018 Oct; 84(10):2175-2177. PubMed ID: 29923203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The failure to fail smartly.
    Galson S; Austin CP; Khandekar E; Hudson LD; DiMasi JA; Califf R; Wagner JA
    Nat Rev Drug Discov; 2021 Apr; 20(4):259-260. PubMed ID: 32968225
    [No Abstract]   [Full Text] [Related]  

  • 5. At a glance: economic impact of industry-sponsored clinical trials of pharmaceutical products.
    Varmaghani M; Heidari E; Reiner Ž; Sahebkar A
    J Med Econ; 2020 Oct; 23(10):1193-1195. PubMed ID: 32580595
    [No Abstract]   [Full Text] [Related]  

  • 6. Improving productivity with model-based drug development: an enterprise perspective.
    Grasela TH; Slusser R
    Clin Pharmacol Ther; 2010 Aug; 88(2):263-8. PubMed ID: 20592720
    [No Abstract]   [Full Text] [Related]  

  • 7. What do clinical pharmacologists do? A questionnaire survey of senior UK clinical pharmacologists.
    Aronson JK
    Br J Clin Pharmacol; 2012 Feb; 73(2):161-9. PubMed ID: 21831197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future trends in outsourcing: a summary of the Bioanalysis Zone Survey.
    Craddock A; Nadarajah S
    Bioanalysis; 2017 Aug; 9(15):1127-1129. PubMed ID: 28766363
    [No Abstract]   [Full Text] [Related]  

  • 9. Update of FDA's Critical Path Initiative.
    Khleif S
    Clin Adv Hematol Oncol; 2009 Mar; 7(3):173-4. PubMed ID: 19398939
    [No Abstract]   [Full Text] [Related]  

  • 10. Criteria for judging proposals for national health care reform with respect to therapeutics.
    Nierenberg DW; Reidenberg MM
    Clin Pharmacol Ther; 1994 Jan; 55(1):1-4. PubMed ID: 8299310
    [No Abstract]   [Full Text] [Related]  

  • 11. [Description of the French players from Avenir's investment program: the role of MabDesign].
    Groux N; Pontremoli R; Vuddamalay G; Richard G; Pons D
    Med Sci (Paris); 2019 Dec; 35(12):1198-1201. PubMed ID: 31903939
    [No Abstract]   [Full Text] [Related]  

  • 12. Developing and delivering clinical pharmacology in pharmaceutical companies.
    Richards D
    Br J Clin Pharmacol; 2012 Jun; 73(6):870-3. PubMed ID: 22360674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uniting Discovery and Care: The Role of Pharmaceutical Companies in Research, Clinical Studies, and Patient Care.
    Tan C; McGill JM; Mallbris L
    J Invest Dermatol; 2020 Mar; 140(3):527-530. PubMed ID: 31972248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The long path (s) of placing medicines on the market].
    Duguet C
    Med Sci (Paris); 2019 Mar; 35 Hors série n° 1():13-17. PubMed ID: 30943154
    [No Abstract]   [Full Text] [Related]  

  • 15. Developing new drugs for cancer.
    Mead GM; Williams CJ
    BMJ; 1991 Oct; 303(6809):1005-6. PubMed ID: 1805823
    [No Abstract]   [Full Text] [Related]  

  • 16. R&D efficiency of leading pharmaceutical companies - A 20-year analysis.
    Schuhmacher A; Wilisch L; Kuss M; Kandelbauer A; Hinder M; Gassmann O
    Drug Discov Today; 2021 Aug; 26(8):1784-1789. PubMed ID: 34022459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating pharmacology and clinical pharmacology in pharmaceutical companies.
    Hunter JA
    Br J Clin Pharmacol; 2012 Jun; 73(6):927-30. PubMed ID: 22360450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical development process.
    Henderson TA
    Int J Dermatol; 1995 Feb; 34(2):94-6. PubMed ID: 7737784
    [No Abstract]   [Full Text] [Related]  

  • 19. [MI-mAbs, pre-industrial demonstrator supported by PIA for the early validation of therapeutic targets using monoclonal antibodies].
    Romagné F
    Med Sci (Paris); 2019 Dec; 35(12):1202-1203. PubMed ID: 31903940
    [No Abstract]   [Full Text] [Related]  

  • 20. Doctors, pharmacy students and drug companies: a first week of research in Pakistan.
    Jamshed S
    JNMA J Nepal Med Assoc; 2009; 48(174):198. PubMed ID: 20387370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.